Patients with iAMP21‐ALL often display secondary genetic abnormalities which include gain of chromosomes X, 10 or 14, or abnormalities involving chromosome 7, deletions of 11q, deletions of ETV6 and RB1 and 12q abnormalities involving SH2B3. This evidence concerns the gene SH2B3 and acute lymphoblastic leukemia.